Scimitar Syndrome is a congenital heart defect that affects the pulmonary veins and the right lung. It is characterized by the anomalous drainage of the pulmonary veins into the inferior vena cava, resulting in a scimitar-shaped shadow on chest X-rays. Symptoms of Scimitar Syndrome include shortness of breath, chest pain, and fatigue. Treatment typically involves corrective surgery to reroute the pulmonary veins and restore normal blood flow.
The Scimitar Syndrome market is a niche segment of the larger cardiology market. It is composed of medical device and pharmaceutical companies that develop and market products for the diagnosis and treatment of Scimitar Syndrome. These products include diagnostic imaging equipment, surgical tools, and medications.
Companies in the Scimitar Syndrome market include Medtronic, Boston Scientific, Abbott, Johnson & Johnson, and St. Jude Medical. Show Less Read more
